HARARE – CAPS Holdings, Zimbabwe’s largest pharmaceutical group, urgently requires $6 million in recapitalisation funds, with the drug-maker currently operating at five...
To access this post, you must purchase a subscription. Please click the button below to visit our subscriptions page to select a package.
Subscriptions 
